Cesar Hernandez-Garcia
Overview
Explore the profile of Cesar Hernandez-Garcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamas-Diaz M, Hernandez-Garcia C
Farm Hosp
. 2020 Jan;
44(1):1-2.
PMID: 31901054
No abstract available.
2.
Leon L, Abasolo L, Fernandez-Gutierrez B, Jover J, Hernandez-Garcia C
Reumatol Clin (Engl Ed)
. 2016 Nov;
14(1):4-8.
PMID: 27810462
Objective: To analyze the resource utilization in rheumatoid arthritis (RA) patients and predictive factors in and patients treated with biological drugs and biologic-naïve. Methods: A cross-sectional study was performed in...
3.
4.
Leon L, Abasolo L, Carmona L, Rodriguez-Rodriguez L, Lamas J, Hernandez-Garcia C, et al.
J Rheumatol
. 2013 Sep;
40(11):1850-5.
PMID: 24037551
Objective: To analyze sociodemographic and clinic-related factors associated with the use of orthopedic surgical procedures in rheumatoid arthritis (RA), focusing on the potential role of new biologic therapies. Methods: A...
5.
Maese J, Garcia de Yebenes M, Carmona L, Hernandez-Garcia C
Reumatol Clin
. 2012 May;
8(5):236-42.
PMID: 22608957
Background: There is a wide variability in the diagnostic and therapeutic methods in rheumatoid arthritis (AR) in Spain, according to prior studies. The quality of care could benefit from the...
6.
Jovani V, Loza E, Garcia de Yebenes M, Descalzo M, Barrio J, Carmona L, et al.
Reumatol Clin
. 2012 Apr;
8(3):114-9.
PMID: 22503152
Objective: Our objective was to describe the variability in the management of spondyloarthritis (SA) in Spain in terms of healthcare resources and their use. Methods: A review of 1168 medical...
7.
Hernandez-Garcia C
Reumatol Clin
. 2011 Sep;
7 Suppl 2:S13-7.
PMID: 21924214
Medicines are strictly regulated and controlled until they reach the patients. Once in the market, the mechanisms governing their use are very complex due to the large number of actors...
8.
Clemente D, Hernandez-Garcia C, Abasolo L, Villaverde V, Lajas C, Loza E, et al.
Reumatol Clin
. 2011 Jul;
3(6):245-50.
PMID: 21794441
Objective: To analyze changes in the lag time to first disease modifying antirheumatic drug (DMARD) prescription since onset of symptoms of rheumatoid arthritis (RA) over the last 2 decades in...
9.
Abasolo L, Carmona L, Lajas C, Candelas G, Blanco M, Loza E, et al.
Arthritis Rheum
. 2008 Apr;
59(4):489-96.
PMID: 18383421
Objective: To identify factors associated with poor outcome in temporary work disability (TWD) due to musculoskeletal disorders (MSDs). Methods: We conducted a secondary data analysis of a 2-year randomized controlled...
10.
Mahr A, Jover J, Spiera R, Hernandez-Garcia C, Fernandez-Gutierrez B, LaValley M, et al.
Arthritis Rheum
. 2007 Aug;
56(8):2789-97.
PMID: 17665429
Objective: To reevaluate the efficacy and safety of adjunctive low-dose methotrexate (MTX) in giant cell arteritis (GCA). Methods: An individual patient data meta-analysis of 3 randomized placebo-controlled trials in patients...